Two commonly used drugs in urology, Mitomycin and Gemcitabine, are included on the NIOSH list. As hazardous medications, USP 800 requires significant investment to safely compound and administer doses of these drugs. Edge Pharma developed a solution that solves this issue for hospitals, surgery centers, and urology clinics. Using this methodology, we are able to apply this technique to other hazardous medications as well.
Sign up to download How Does USP 800 Affect Urology Practices?
Our records indicate your email already exists. Please login above.
When you register to become a member, you gain access to white papers and the ability to reach out to companies directly. As part of your membership, we’ll keep you up-to-date on current news, research and analysis with our Business Chatter Weekly e-Newsletter.